There were no in-hospital deaths in any of these patients. This protocol appears safe, can be systematically applied to include all patients who present with CP, and will thus help maximize resource utilization by appropriately triaging patients and reducing LOS.
Emergent myocardial perfusion imaging IMPI) has been shown to be accurate in diagnosis of acute MI. We assessed the financial and pt outcome implications of such imaging.
Method: 50 pts presenting to emergency center (Ee) with unexplained chest pain received resting Tc99m-sestamibi SPECT MPI as part of their EC evaluation with a gamma camera dedicated to this purpose. If resting scan was nl, adenosine stress imaging was performed in EC at cardiologist's (MOl discretion. Influence of MPI was determined by MD questionnaire completed immediately before and after MPI results were made available. Cost savings analysis was based on pre-vs post-MPI management strategy and historical analysis of costs. 45 pts were followed avg 9 months post MPI.
Results: MPI altered pt management in 34/50 pts (68%).29 pts were sent home rather than admitted based on EC MPI. 9/21 admitted pts were sent to lower intensity beds. Total cost savings was $88,533 ($1771/pt). 35 pts were asymptomatic on follow-up, 8 had recurrent chest pain and 6 had at least 1 EC visit for chest pain. No pt with nl MPI had a major cardiac event or revascularization on follow-up.
Conclusion:
The use of acute EC SPECT MPI is a cost effective means of assigning pts to a low risk group that may be followed safely on an outpatient basis.
Recent studies suggest the mechanism of sudden death in congestive heart failure (CHF) patients is less frequentlyVTNF than previously believed. In order to further understand the characteristics and mechanisms of death in CHF patients, we evaluated 146 patients who underwent cardiopulmonary resuscitation during hospitalization for congestive heart failure, ischemic heart disease, and noncardiac causes. Clinical characteristics and outcomes are described below:
Automated external defibrillators use ECG analysis algorithms to identifyventricular fibrillation IVF) and ventricular tachycardia (VT). VT can be associated with a wide range of blood pressures and automated defibrillators determine the need for DC shock based on the heart rate alone. The incorporation of a hemodynamic sensor may improve the accuracy of an automated defibrillator. The impedance cardiogram (ICG) has been used to non-invasively measure cardiac output and its peak value, dz/dt(max), correlates well with aortic blood flow. We have developed a system whereby the ICG can be recorded at cardiac arrests through the same two ECG/defibrillator pads, placed in an antero-apical position, that are used to monitor or shock the patient. At 103 cardiac arrest calls and in 20 healthy volunteers (C) the ICG was recorded for a period of at least lOs without CPR artefact: 9 records were rejected because of poor quality. The rhythms were divided into VF, asystole (As). agonal rhythm lAg), electromechanical dissociation (EMD). VT requiring DC shock (VTs) and VT not requiring DC shock (VTns). The ICG tracings were ensemble averaged to remove any electrical noise and dz/dt(max) was measured.
C was significantly greater than all other rhythms. VTns was significantly greater than the pulseless rhythms EMD, Ag, VF and As. There was no significant difference between VTs and the pulseless rhythms. Thus the ICG is a potential hemodynamic sensor for automated external defibrillators. 
Characteristic Mechanisms and Outcome of Cardiopulmonary Arrest in Congestive Heart Failure Patients
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What "Dose" of Oxygen is Required in Treating Prolonged Cardiac Arrest
A Systematic Approach to the Evaluation of Chest Pain in the Emergency Department: A Prospective Risk Assessment and Treatment Protocol Based on Patient Presentation, ECG and Rest Technetium 99m-Sestamibl
Introduction: Selective aortic (Ao) perfusion and oxygenation (SAPO) with oxygenated ultra-purified polymerized bovine hemoglobin (UPBH) is an effective adjunct to ACLS in the treatment of cardiac arrest. The optimal volume of oxygenated UPBH, equivalent to a dosage of oxygen, is not known.
Purpose: Determine the doselresponse relationship between intra-Ao UPBH and return of spontaneous circulation (ROSC).
Methods: Randomized, interventional study using a canine model of VF with a prolonged "down-time" and CPR based on external chest compression. After chloralose anesthesia, the blood gases and vital signs were normalized. ECG, Ao arch and intra-esophageal pressures were measured continuously, A descending Ao occlusion-infusion balloon catheter was placed through the femoral artery. Ventricular fibrillation was induced and BLS begun after 10 min, Inter-animal differences in BLS were minimized by standardization of esophageal pulse pressure and Ao blood gases. At 13 min. the Ao occlusion balloon was inflated and 10,20 or 30 cclkg of UPBH (equivalent to 1.8,3.6, and 5.4 ml 021kg) was infused at 300 cc/min. Defibrillation with 8 Jlkg was attempted at end infusion. Results: N = 17. Only 2 of 5 animals given 10 cc/kg of UPBH had ROSC, verses 4 of 5 given 20 cclkg, and all 7 animals given 30 cclkg had ROSC (p = 0.05). All resuscitated animals were alive at one hour. Conclusions: There is a dose-response relationship between the volume of oxygen administered by SAPO and the rate of ROSC after prolonged cardiac arrest. Thirty cc/kg of UPBH, equivalent to 5.4 ml 021kg, appeared optimal in this model. Ideal treatment of acute myocardial infarction (AMI) and unstable angina (UA) require rapid evaluation and triage in the ED. Appropriate patient triage and disposition can reduce admissions and optimize resource utilization including reduced CCU length of stay (LOS). Historically less than 20 percent of patients admitted with chest pain (CP) rule in for AMI. However, all patients must be initially evaluated in the same fashion until the risk of AMI or UA can be determined and appropriate treatment initiated. Given the diagnostic limitation of the presenting symptoms and initial ECG, we designed and are prospectively testing a systemic protocol to evaluate all patients who present to the ED with CP All patients are assigned to one of five levels based on risk and probability of AMI and of ischemia: 1. AMI; 2. Probable AMI/UA; 3. Possible AMI/UA; 4. Possible UA; and 5. Non-cardiac CPO In the absence of a diagnostic ECG needed for assignment to levell, (ST elevation), or level 2, (ST depression). immediate injection of Tc99m-sestamibi in the ED is used to further stratify patients in levels 3 and 4. If the evaluation of any given patient becomes positive, the assigned level is increased to one of higher risk with appropriate changes in therapy.
Since January 1994, 560 patients with potential cardiac chest pain have been enrolled into levels 1-4. Level 5 patients were treated for obvious noncardiac causes. Predicted risk of AMI with distribution of patients and actual incidence of AMI is as follows: Patients with nonCHF/Cardiac disease had a higher ROSC than patients with CHF and noncardiac diseases (p = 0.016). In summary, patients with CHF often experience cardiopulmonary arrest with bradycardic or EMD arrests. Although patients with CHF are resuscitated with a high degree of success their in-hospital survival was low. Furthermore, the high rate of bradycardic and EMD arrests may explain the low in-hospital survival rates. Burst antitachycardia pacing (ATP) is higly efficacious for termination of monomorphic ventricular tachycardia (MVT). Since several pacing sequences are usually programmed as a single therapy. optimal programming is presently unknown. In 40 patients (P) with MVT and a 3rd generation AICD, 4 burst ATP were prospectively compared (as a first single ATP) during followup in a randomized design crossing over every 2-3 months. Burst ATP modes (A to D) were defined by pacing cycle length (PCl, as % of VTCl) and number of beats (No B) (Table) . A second ATP zone was programmed in a non selected way in all patients. 
Implantation of a Single-Lead Unipolar Transvenous Cardioverter/Defibrillatior (ICD) Under Local Anesthesia
Results (
University of Vienna, Austria
The purpose of this study was to prospectively evaluate single-lead unipolar transvenous ICD implantation under local anesthesia and defibrillator threshold testing under mild sedation.
In 12 consecutive patients (mean age. 61 ± 10 years) transvenous ICD implantation was performed (9 patients had ischemic heart disease. 3 patients dilated cardiomyopathy). The presenting arrhythmia was ventricular fibrillation in 4 patients. and monomorphic ventricular tachycardia in 8 patients.
Mean lVEF was 26 ± 11 %. A single-lead unipolar transvenous ICD with biphasic defibrillation pulse was implanted subpectorally in all patients under local anesthesia with 1% lidocaine. During defibrillation threshold (OFT) testing sedation was applied with 11.5 ± 5.1 mg (0.14 ± 0.05 mglkg) midazolam. For DFT determination 5.8 ± 1.3 episodes of ventricular fibrillation (mean total ventricular fibrillation time 52.4 ± 14.7 seconds) were induced.
Mean OFT was 12.8 ± 4.3 J. mean duration of the implantation procedure was 58 ± 13 minutes. Heart rate. mean arterial blood pressure. and arterial oxygen saturation were not significantly different before and after DFT determination. One patient had moderate pain during DFT testing. and 3 patients had mild pain during the surgical procedure. Symptoms during the procedure were evaluated using a standardized questionnaire. Severe feeling of panic and surprise, and discomfort of moderate degree was reported by 2 patients. There were no complications. Hospital length of stay: all patients were discharged on the second postoperative day. Postimplant ICD testing was performed successfully without sedation 35 ± 1.4 days after ICD implantation, in 6 patients as an outpatient procedure.
Conclusions:
Single-lead unipolar transvenous ICD systems can safely be implanted under local anesthesia and mild sedation during defibrillation threshold testing. The procedure is well tolerated. 
